Fibrates and high-dose statins to prevent coronary heart disease events

被引：1
|
作者：
Jones P.H. [1 ]
机构：
[1] Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston
来源：
Current Cardiology Reports | 1999年 / 1卷 / 3期
关键词：
Atorvastatin; Bezafibrate; Coronary Heart Disease Event; Postprandial Lipemia; Bezafibrate Infarction Prevention;
D O I：
10.1007/s11886-999-0026-8
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：223 / 224
页数：1
相关论文
共 50 条
  • [31] Impact of High-Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years
    Koren, Michael J.
    Feldman, Theodore
    Mendes, Robert A.
    CLINICAL CARDIOLOGY, 2009, 32 (05) : 256 - 263
  • [32] High-dose but not low-dose atorvastatin improves endothelial function of patients with coronary artery disease: Functional evidence for pleiotropic effects of statins
    Warnholtz, A
    Eggeling, S
    Ostad, MA
    Tschentscher, P
    Baldus, S
    Munzel, T
    CIRCULATION, 2004, 110 (17) : 80 - 80
  • [33] Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease
    Fruchart, JC
    Brewer, B
    Leitersdorf, E
    Brochier, M
    Brown, G
    Calvo, C
    Carmena, R
    Ceska, R
    Loy-Soong, WC
    Davignon, J
    Gotto, A
    Grundy, S
    Hamsten, A
    Keech, A
    Matsuzawa, Y
    Patch, JR
    Paoletti, R
    Raslova, K
    Smirnov, V
    Steiner, G
    Thompson, G
    Zhu, JR
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (07): : 912 - +
  • [34] LONG-TERM EFFECTS OF LOW-DOSE OR HIGH-DOSE MOLSIDOMINE ADMINISTERED FOR CORONARY HEART-DISEASE
    JANSEN, W
    OSTERSPEY, A
    MEYER, L
    EGGELING, T
    TAUCHERT, M
    ZEITSCHRIFT FUR KARDIOLOGIE, 1985, 74 : 70 - 70
  • [35] Comparative Antiplatelet Efficacy of Prasugrel and High-Dose Clopidogrel in Patients With Coronary Heart Disease Including Acute Coronary Syndrome
    Pakhomov, Ya M.
    KARDIOLOGIYA, 2012, 52 (03) : 82 - 85
  • [36] How could use of genetic markers prevent coronary heart disease events?
    Ripatti, Samuli
    Salomaa, Veikko
    PERSONALIZED MEDICINE, 2013, 10 (08) : 769 - 771
  • [37] High-dose statin therapy in patients with coronary artery disease
    Trouton, T. G.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2005, 35 (02): : 110 - 111
  • [38] Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events.
    Muhlestein J.B.
    Current Atherosclerosis Reports, 2000, 2 (4) : 336 - 341
  • [39] IMPACT OF DIABETES MELLITUS ON THE HIGH-DOSE STATINS PRESCRIPTION AFTER ACUTE CORONARY SYNDROMES.
    Lopez-Cuenca, A.
    Sanchez-Galian, M. J.
    Flores-Blanco, P. J.
    Sanchez-Martinez, M.
    Navarro-Penalver, M.
    De las Heras Gomez, I.
    Garcia-Narbon, A.
    Marin, F.
    Valdes, M.
    Manzano-Fernandez, S.
    CARDIOLOGY, 2013, 126 : 178 - 178
  • [40] More support for high-dose atorvastatin in coronary artery disease
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (13) : 2365 - 2368
12345